Trial intelligence / Profile preview

Steroid-Free, Calcineurin-Sparing Protocol for HLA-Identical Kidney Transplant

NCT00352092Phase 4Completed

Sponsor
University of Cincinnati
Start
Jun 2002
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate mofetil in kidney transplant rejection, sponsored by University of Cincinnati. Started Jun 2002; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00352092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00352092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call